| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/25/2004 | EP1390053A2 Hcg formulation |
| 02/25/2004 | EP1390021A1 Delivery of compounds for the treatment of migraine through an inhalation route |
| 02/25/2004 | EP1390018A1 A pharmaceutical tablet having a high api content |
| 02/25/2004 | EP1390011A2 Control of compactability through crystallization |
| 02/25/2004 | EP1389997A2 Methods and compositions for stable transgenic plant pharmaceuticals and their use as contraceptives |
| 02/25/2004 | EP1263756B1 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha |
| 02/25/2004 | EP1232158B1 Anti-inflammatory oxo derivatives and hydroxy derivatives of pyrrolizines, and their pharmaceutical use |
| 02/25/2004 | EP1230232B1 Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 02/25/2004 | EP1222171B1 Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof |
| 02/25/2004 | EP1210326B1 Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors |
| 02/25/2004 | EP1178986B1 Furanone derivatives as inhibitors of cathepsin s |
| 02/25/2004 | EP1137341B1 Baby food stimulating growth of the thymus |
| 02/25/2004 | EP1135481B1 New oligomeric conjugates liable to transfer biological molecules into cells |
| 02/25/2004 | EP1087934B1 Aminocyclohexyl ether compounds and uses thereof |
| 02/25/2004 | EP0873301B1 Indane compounds with smooth muscle relaxing and/or mast cell stabilising and/or anti-inflammatory activity |
| 02/25/2004 | EP0790059B1 Means for treating auto-immune diseases |
| 02/25/2004 | EP0751957B1 Peptide fragments of microbial stress proteins and pharmaceutical composition made thereof for the treatment and prevention of inflammatory diseases |
| 02/25/2004 | EP0665888B1 Ryegrass pollen allergen |
| 02/25/2004 | CN1478098A Modulation of IL-2-and IL-15-mediated T cell responses |
| 02/25/2004 | CN1478087A Indolylmaleimide derivatives as protein kinase C inibitors |
| 02/25/2004 | CN1478084A Compounds useful in treatment of inflammatory diseases |
| 02/25/2004 | CN1477972A Method for botaining antigenic aggregates and use thereof in formulations |
| 02/25/2004 | CN1477968A Methods for treating rheumatic diseases using soluble CTLA4 molecule |
| 02/25/2004 | CN1477960A EPA receptor inhibitors to treat rheumatoid arthritis |
| 02/25/2004 | CN1476878A Medicine tea with function of raising immunity, resisting fatigue and preventing impotence and prospermia |
| 02/25/2004 | CN1476849A Medicine composition for promoting blood circulation and removing stasis |
| 02/25/2004 | CN1476843A Application of nano copper powder in preparation of immunopotentiator medicine |
| 02/25/2004 | CN1139595C Crystalline macrolides and its preparation method |
| 02/25/2004 | CN1139387C Epimedium polysaccharide and its preparing method, and its application in preparing medicine for raising body's immunity |
| 02/25/2004 | CN1139386C Oral pharmaceutical composition of piperidinoalkanol compounds in solution form |
| 02/24/2004 | US6697668 Ocular iontophoretic device and method for using the same |
| 02/24/2004 | US6696567 Pyrrolo[2,3-d]pyrimidine compounds |
| 02/24/2004 | US6696566 Selective p38 kinase inhibitors relative to cyclin-dependent kinases and tyrosine kinases |
| 02/24/2004 | US6696547 Mutant DEDD proteins for regulating apoptosis |
| 02/24/2004 | US6696545 Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation |
| 02/24/2004 | US6696470 Pyridylthiophene compounds |
| 02/24/2004 | US6696458 Having x-ray powder diffraction pattern with lines at degrees 2 theta values 6.7, 12.5, 14.0 and 23.9 for cu k alpha radiation of wavelength 1.5406 angstrom |
| 02/24/2004 | US6696457 Morphinoid compounds |
| 02/24/2004 | US6696452 Glycogen synthase kinase-3 and aurora-2 a serine/threonine protein kinase inhibitors; antidiabetic and anticancer agents and alzheimer's disease treatments |
| 02/24/2004 | US6696446 Benzoylpyridazines, their preparation and use |
| 02/24/2004 | US6696422 Parenterally administering product r, a peptide-nucleic acid preparation, in combination with one or more antiviral agents useful for treating aids or hiv infections including hiv protease inhibitors and nucleosides |
| 02/24/2004 | US6696263 PCNA associated cell cycle proteins, compositions and methods of use |
| 02/24/2004 | US6696076 Administering imidazoquinoline amine or imidazopyridine amine as interleukin and cytokine inhibitor |
| 02/24/2004 | US6696062 BASB006 polypeptides from Neisseria meningitidis and immunogenic compositions thereof |
| 02/24/2004 | CA2293461C Alkyl-4-silylheterocyclic phenols and thiophenols as antioxidant agents |
| 02/24/2004 | CA2279186C Sulfonyl urea derivatives and their use in the control of interleukin-1 activity |
| 02/24/2004 | CA2013518C Derivatives of thieno-triazolo-diazepine, a preparation process of the same and therapeutic compositions containing them |
| 02/19/2004 | WO2004015118A1 Vaccinia virus host range genes to increase the titer of avipoxviruses |
| 02/19/2004 | WO2004015099A2 Vaccine composition comprising lipooligosaccharide with reduced phase variability |
| 02/19/2004 | WO2004015096A2 Leech extracts for stents |
| 02/19/2004 | WO2004015062A2 Methods and compositions relating to gene silencing |
| 02/19/2004 | WO2004015057A2 Mucin-immunoglobulin fusion proteins |
| 02/19/2004 | WO2004014958A1 Polysaccharide of echinacea angustifolia |
| 02/19/2004 | WO2004014927A1 Mitochondrially targeted antioxidants |
| 02/19/2004 | WO2004014923A1 Pyrimidinone fused bicyclic metalloproteinase inhibitors |
| 02/19/2004 | WO2004014920A1 Bicyclic heteroaromatic compounds as kinase inhibitors |
| 02/19/2004 | WO2004014913A2 Derivatives of 2-trifluormethyl-6-aminopurine as phosphodiesterase 4 inhibitors |
| 02/19/2004 | WO2004014911A1 Phosphodiesterase 4 inhibitors |
| 02/19/2004 | WO2004014910A1 Dihydropyrazolopyridine compounds |
| 02/19/2004 | WO2004014905A1 Substituted benzimidazole compounds |
| 02/19/2004 | WO2004014903A1 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors |
| 02/19/2004 | WO2004014859A2 Process for preparing quinolin antibiotic intermediates |
| 02/19/2004 | WO2004014851A2 Tyrosine kinase inhibitors |
| 02/19/2004 | WO2004014847A1 Mcp-1 receptor antagonists and method of use thereof |
| 02/19/2004 | WO2004014844A2 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 02/19/2004 | WO2004014825A1 Cannabinoid receptor ligands |
| 02/19/2004 | WO2004014430A1 Compositions of a cyclooxygenase-2 selective inhibitor and a carbonic anhydrase inhibitor for the treatment of neoplasia |
| 02/19/2004 | WO2004014422A1 A method of immunomodulation |
| 02/19/2004 | WO2004014419A1 Vaccine composition comprising transferrin binding protein and hsf from gram negative bacteria |
| 02/19/2004 | WO2004014418A2 Neisserial vaccine compositions comprising a combination of antigens |
| 02/19/2004 | WO2004014417A2 Vaccine compositions comprising l2 and/or l3 immunotype lipooligosaccharides from lgtb- neisseria minigitidis |
| 02/19/2004 | WO2004014414A1 Novel uses of rfrp and ot7t022 |
| 02/19/2004 | WO2004014394A1 Antipruritic agent |
| 02/19/2004 | WO2004014382A1 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds |
| 02/19/2004 | WO2004014374A1 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 02/19/2004 | WO2004014373A1 Pharmaceutical compositions comprising fk506 derivatives and the ir use for the treatment of allergic diseases |
| 02/19/2004 | WO2004014353A1 Pharmaceutical formulations comprising combinations of epinastine, pseudoephedrine and methylephedrine |
| 02/19/2004 | WO2004014352A2 Methods for treating carbonic anhydrase mediated disorders |
| 02/19/2004 | WO2004014304A2 Electrospun amorphous pharmaceutical compositions |
| 02/19/2004 | WO2004007481A3 Substituted amine derivatives and methods of use in the treatment of angiogenesis relates disorders |
| 02/19/2004 | WO2004007478A3 Derivatives of 3-guanidinocarbonyl-1-heteroaryl-pyrrole, process for their preparation and their pharmaceutical use |
| 02/19/2004 | WO2003097852A3 Assay for identifying inhibitors of fc gamma riii signaling |
| 02/19/2004 | WO2003088979A3 Oligonucleotides from sequences coding for the surface component of envelope proteins of primate t-cell leukaemia/lymphoma viruses (ptlv) and uses thereof |
| 02/19/2004 | WO2003078658A3 Methods for diagnosing and treating schizophrenia |
| 02/19/2004 | WO2003070188A3 Method of treating trx mediated diseases |
| 02/19/2004 | WO2003065987A3 Granzyme b inhibitors |
| 02/19/2004 | WO2003065046A3 Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor |
| 02/19/2004 | WO2003059255A3 Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol |
| 02/19/2004 | WO2003048780A3 Uses of aldose-1-epimerase (mutarotase) for diagnosis and therapy of inflammatory diseases and sepsis |
| 02/19/2004 | WO2003048193A3 GIPs, A FAMILY OF POLYPEPTIDES WITH TRANSCRIPTION FACTOR ACTIVITY THAT INTERACT WITH GOODPASTURE ANTIGEN BINDING PROTEIN |
| 02/19/2004 | WO2003045974A3 Methods and compositions for derepression of iap-inhibited caspase |
| 02/19/2004 | WO2003030947A3 Concentrated x-ray contrast media can act as universal antigens and can inhibit or prevent allergic reactions |
| 02/19/2004 | WO2003025014A3 Use of peptides comprising post-translational modifications in the treatment of autoimmune pathologies |
| 02/19/2004 | WO2003014731A3 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 02/19/2004 | WO2002081496A3 Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours |
| 02/19/2004 | WO2002078736A3 Antiallergic pharmaceutical composition |
| 02/19/2004 | WO2002065985A3 Methods of treating diabetes mellitus |
| 02/19/2004 | WO2002064160A3 Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof |
| 02/19/2004 | WO2002061086A3 Human leucine-rich repeat containing protein expressed predominately in small intestine, hlrrsi1 |
| 02/19/2004 | WO2002048337A3 Secreted human proteins |